We strive to bring the technology we create closer to you. Our discoveries in the areas of genomics and artificial intelligence are unique and contribute to the fast-paced fight against cancer.
A pilot study utilizing 4174 samples from The Cancer Genome Atlas (#TCGA) has published results of a 77.6% accuracy in predicting cancer types using the raw tumor sequences that integrate all somatic mutations and germline variants.